The present study shows that SOX30 expression is considerably lower in BC than in adjacent normal tissues and that poor survival in BC as well as advanced TNM stages are significantly linked to lower SOX30 expression (P < 0.05 for both). The gene discussed is SOX30; the disease is breast cancer.